Cano, A, Capdevila, M, Puerta, R, Arranz, J, Montrreal, L, de Rojas, I, García-González, P, Olivé, C, García-Gutiérrez, F, Sotolongo-Grau, O, Orellana, A, Aguilera, N, Ramis, M, Rosende-Roca, M, Lleó, A, Fortea, J, Tartari, JP, Lafuente, A, Vargas, L, Pérez-Cordón, A, Muñoz, N, Sanabria, A, Alegret, M, Morató, X, Tárraga, L, Fernández, V, Marquié, M, Valero, S, Alcolea, D, Boada, M, Ruiz, A. Clinical value of plasma pTau181 to predict Alzheimer's ' s disease pathology in a large real-world cohort of a memory clinic. EBioMedicine. 2024; 108DOI:10.1016/j.ebiom.2024.105345. PMID:39299003. IF:10.800(Q1/1D).

Pascoal, TA, Aguzzoli, CS, Lussier, FZ, Crivelli, L, Suemoto, CK, Fortea, J, Rosa-Neto, P, Zimmer, ER, Ferreira, PCL, Bellaver, B. Insights into the use of biomarkers in clinical trials in Alzheimer's ' s disease. EBioMedicine. 2024; 108DOI:10.1016/j.ebiom.2024.105322. PMID:39366844. IF:10.800(Q1/1D).

Carmona-Iragui, M, 'Connor, AO, Llibre-Guerra, J, Lao, PT, Ashton, NJ, Fortea, J, Sánchez-Valle, R. Clinical and research application of fluid bio markers in autosomal dominant Alzheimer's disease and Down syndrome. EBioMedicine. 2024; 108DOI:10.1016/j.ebiom.2024.105327. PMID:39366843. IF:10.800(Q1/1D).

Schöll, M, Verberk, IMW, del Campo, M, Delaby, C, Therriault, J, Chong, JR, Palmqvist, S, Alcolea, D. Challenges in the practical implementation of blood biomarkers for Alzheimer's disease. Lancet Healthy Longevity. 2024; 5(10)DOI:10.1016/j.lanhl.2024.07.013. PMID:39369727. IF:14.600(Q1/1D).